Dr. Scott Gottlieb warned Thursday about the probable for extensive-time period mind reduction involved with Covid, citing a new analyze from the United Kingdom.
“In small, the review implies that there could be some extended-expression decline of brain tissue from Covid, and that would have some long-phrase repercussions,” the previous Fda main and CNBC contributor said.
“You could compensate for that around time, so the signs and symptoms of that may possibly go absent, but you’re never going to regain the tissue if, in point, it is becoming ruined as a outcome of the virus,” said Gottlieb, who serves on the board of Covid vaccine-maker Pfizer.
The U.K. examine examined brain imaging in advance of and soon after a coronavirus an infection and looked precisely at the probable effect on the nervous procedure.
Gottlieb described to CNBC’s “The News with Shepard Smith” that the destruction of mind tissue could describe why Covid sufferers shed their perception of smell.
“The diminishment in the volume of cortical tissue happened to be in regions of the brain that are near to the areas that are accountable for smell,” he reported. “What it implies is that, the smell, the decline of scent, is just an result of a more most important course of action that’s underway, and that system is in fact shrinking of cortical tissue.”
Disclosure: Scott Gottlieb is a CNBC contributor and is a member of the boards of Pfizer, genetic testing begin-up Tempus, wellness-treatment tech firm Aetion Inc. and biotech corporation Illumina.